
Apple’s innovative and groundbreaking step into the healthcare industry has just taken a significant leap forward with the announcement of their AirPods Pro 2 being approved by the Food and Drug Administration (FDA) as hearing aids. This game-changing news comes after months of anticipation, and it signifies Apple’s commitment to expanding its reach in the health sector.
As reported by Forbes, this is not just another addition to the tech giant’s existing products; it marks a significant milestone in the realm of healthcare. With their new feature, users can now manage and assess their hearing loss using only an iPhone or iPad, without requiring any audiologist involvement. This innovative approach sets Apple apart from other companies that have launched over-the-counter (OTC) hearing aids since the FDA’s rule change in 2022.
The AirPods Pro 2 update comes with two exciting new features: the ability to detect and manage early-stage hearing loss, as well as a passive mode that reduces exposure to loud environmental noise. This advancement has sparked curiosity and excitement among tech enthusiasts and medical professionals alike.
In this article, we will dive deeper into what these changes mean for consumers and the broader implications on the healthcare landscape.
The announcement is a significant step in Apple’s growing presence in health technology, which includes previous features such as heart-rate tracking and fall detection.
Source: www.forbes.com